For three decades, Rush University Medical Center in Chicago — a principal member of the National Cancer Institute's Gynecology Oncology Group — has paved the way in the multidisciplinary treatment of gynecologic cancers. Established in 1972, the Gynecologic Cancer Center at Rush was one of the first in the region to fight gynecological cancers with a team approach. This approach enables patients to see specialists in the areas of gynecologic oncology and medical oncology and receive a personalized treatment plan in a single visit.

The Gynecologic Cancer Center at Rush provides care to individuals at risk for, or diagnosed with, the following:

• Cervical cancer
• Endometrial cancer
• Ovarian cancer
• Uterine cancer
• Vaginal cancer
• Vulvar cancer

In addition to providing evaluation, diagnosis and treatment for women with gynecologic cancers, our comprehensive, multidisciplinary center offers the following:

• Advanced treatment options
• Genetic testing and counseling
• Supportive services
• Clinical trials for gynecologic cancers
• Second opinion services

For more information about the services provided, please visit Our Services.

Jacob Rotmensch, MD, leads Gynecologic Cancer Center at Rush. Rotmensch is one of the country's foremost experts in the field of gynecologic cancers. As a result of his dedication to his patients and the treatment of gynecologic cancers, Chicago Magazine has twice honored Rotmensch as one of Chicago's Top Doctors.

Our clinical team includes:

• Medical Director: Jacob Rotmensch, MD
• Medical Oncologist: Lydia Usha, MD
• Physician Assistant: Heather Gannon, MS, PA-C
• Nurse Research Coordinator: Lois Winkleman, MS, RN